GPhA And Actavis Divorcing: Biosimilars Behind The Rift

Actavis, the hybridizing generics giant that once helped keep GPhA together, now appears to be splitting off in a dispute over state substitution strategy.

ORLANDO – The Generic Pharmaceutical Association’s annual meeting from Feb. 18-21 was the group’s biggest ever, with 725 attendees. But it would have been more joyous if the association had not been in the midst of a breakup with one of its most prominent members, Allergan PLC.

Actavis has decided not renew its membership in the association. The problem, at least from GPhA’s perspective, seems to be...